Choosing important health outcomes for comparative effectiveness research: An updated systematic review and involvement of low and middle income countries

被引:68
作者
Davis, Katherine [1 ]
Gorst, Sarah L. [1 ]
Harman, Nicola [1 ]
Smith, Valerie [2 ]
Gargon, Elizabeth [1 ]
Altman, Douglas G. [3 ]
Blazeby, Jane M. [4 ]
Clarke, Mike [5 ]
Tunis, Sean [6 ]
Williamson, Paula R. [1 ]
机构
[1] Univ Liverpool, Dept Biostat, MRC North West Hub Trials Methodol Res, Liverpool, Merseyside, England
[2] Trinity Coll Dublin, Sch Nursing & Midwifery, Dublin, Ireland
[3] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford, England
[4] Univ Bristol, Bristol Med Sch, MRC ConDuCT Hub Trials Methodol Res 2, Populat Hlth Sci, Bristol, Avon, England
[5] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland
[6] World Trade Ctr Baltimore, CMTP, Baltimore, MD USA
关键词
WORKING GROUP; TRIALS; CORE; SET; PREECLAMPSIA; STRATEGY; WASTE;
D O I
10.1371/journal.pone.0190695
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Core outcome sets (COS) comprise a minimum set of outcomes that should be measured and reported in all trials for a specific health condition. The COMET (Core Outcome Measures in Effectiveness Trials) Initiative maintains an up to date, publicly accessible online database of published and ongoing COS. An annual systematic review update is an important part of this process. Methods This review employed the same, multifaceted approach that was used in the original review and the previous two updates. This approach has identified studies that sought to determine which outcomes/domains to measure in clinical trials of a specific condition. This update includes an analysis of the inclusion of participants from low and middle income countries (LMICs) as identified by the OECD, in these COS. Results Eighteen publications, relating to 15 new studies describing the development of 15 COS, were eligible for inclusion in the review. Results show an increase in the use of mixed methods, including Delphi surveys. Clinical experts remain the most common stakeholder group involved. Overall, only 16% of the 259 COS studies published up to the end of 2016 have included participants from LMICs. Conclusion This review highlights opportunities for greater public participation in COS development and the involvement of stakeholders from a wider range of geographical settings, in particular LMICs.
引用
收藏
页数:14
相关论文
共 24 条
[11]   Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and User Survey [J].
Gorst, Sarah L. ;
Gargon, Elizabeth ;
Clarke, Mike ;
Blazeby, Jane M. ;
Altman, Douglas G. ;
Williamson, Paula R. .
PLOS ONE, 2016, 11 (01)
[12]   Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - Report from OMERACT CTD-ILD Working Group [J].
Khanna, Dinesh ;
Mittoo, Shikha ;
Aggarwal, Rohit ;
Proudman, Susanna M. ;
Dalbeth, Nicola ;
Matteson, Eric L. ;
Brown, Kevin ;
Flaherty, Kevin ;
Wells, Athol U. ;
Seibold, James R. ;
Strand, Vibeke .
JOURNAL OF RHEUMATOLOGY, 2015, 42 (11) :2168-2171
[13]   Core Outcome Set-STAndards for Reporting: The COS-STAR Statement [J].
Kirkham, Jamie J. ;
Gorst, Sarah ;
Altman, Douglas G. ;
Blazeby, Jane M. ;
Clarke, Mike ;
Devane, Declan ;
Gorgon, Elizabeth ;
Moher, David ;
Schmitt, Jochen ;
Tugwell, Peter ;
Tunis, Sean ;
Williamson, Paula R. .
PLOS MEDICINE, 2016, 13 (10)
[14]   Outcome measures in rheumatoid arthritis randomised trials over the last 50 years [J].
Kirkham, Jamie J. ;
Boers, Maarten ;
Tugwell, Peter ;
Clarke, Mike ;
Williamson, Paula R. .
TRIALS, 2013, 14
[15]   Biomedical research: increasing value, reducing waste [J].
Macleod, Malcolm R. ;
Michie, Susan ;
Roberts, Ian ;
Dirnagl, Ulrich ;
Chalmers, Iain ;
Ioannidis, John P. A. ;
Salman, Rustam Al-Shahi ;
Chan, An-Wen ;
Glasziou, Paul .
LANCET, 2014, 383 (9912) :101-104
[16]   Clinicians' perspective on key domains in ANCA-associated vasculitis: a Delphi exercise [J].
Milman, N. ;
Boonen, A. ;
Tugwell, P. ;
Merkel, P. A. .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2017, 46 (02) :112-117
[17]   Strategy for Standardization of Preeclampsia Research Study Design [J].
Myatt, Leslie ;
Redman, Christopher W. ;
Staff, Anne Cathrine ;
Hansson, Stefan ;
Wilson, Melissa L. ;
Laivuori, Hannele ;
Poston, Lucilla ;
Roberts, James M. .
HYPERTENSION, 2014, 63 (06) :1293-1301
[18]   International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials [J].
Orbai, Ana-Maria ;
de Wit, Maarten ;
Mease, Philip ;
Shea, Judy A. ;
Gossec, Laure ;
Leung, Ying Ying ;
Tillett, William ;
Elmamoun, Musaab ;
Duffin, Kristina Callis ;
Campbell, Willemina ;
Christensen, Robin ;
Coates, Laura ;
Dures, Emma ;
Eder, Lihi ;
FitzGerald, Oliver ;
Gladman, Dafna ;
Goel, Niti ;
Grieb, Suzanne Dolwick ;
Hewlett, Sarah ;
Hoejgaard, Pil ;
Kalyoncu, Umut ;
Lindsay, Chris ;
McHugh, Neil ;
Shea, Bev ;
Steinkoenig, Ingrid ;
Strand, Vibeke ;
Ogdie, Alexis .
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (04) :673-680
[19]  
Rosala-Hallas A, TRIALS IN PRESS
[20]   Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: Recommendations from the prostate-specific antigen working group [J].
Scher, HI ;
Eisenberger, M ;
D'Amico, AV ;
Halabi, S ;
Small, EJ ;
Morris, M ;
Kattan, MW ;
Roach, M ;
Kantoff, P ;
Pienta, KJ ;
Carducci, MA ;
Agus, D ;
Slovin, SF ;
Heller, G ;
Kelly, WK ;
Lange, PH ;
Petrylak, D ;
Berg, W ;
Higano, C ;
Wilding, G ;
Moul, JW ;
Partin, AN ;
Logothetis, C ;
Soule, HR .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) :537-556